nccn guideline hcc的相關文章
nccn guideline hcc的相關公司資訊
nccn guideline hcc的相關商品
Ramucirumab Misses Primary Endpoint in Phase III HCC Trial
瀏覽：1182
日期：2026-04-26
The phase III REACH trial, which examined ramucirumab (Cyramza) for the second-line treatment of patients with hepatocellular carcinoma (HCC), failed to meet its primary endpoint of overall survival (OS), as announced by Eli Lilly and Company, the sponsor...看更多
網友正在看
熱門 保護套 文章
熱門 四門轎跑車 文章
